Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Closed-loop glucose control: psychological and behavioral considerations.

Gonder-Frederick L, Shepard J, Peterson N.

J Diabetes Sci Technol. 2011 Nov 1;5(6):1387-95. Review.

2.

The Impact of Technology on Current Diabetes Management.

Garvey K, Wolfsdorf JI.

Pediatr Clin North Am. 2015 Aug;62(4):873-88. doi: 10.1016/j.pcl.2015.04.005. Epub 2015 May 16. Review.

PMID:
26210622
3.

Holistic Impact of Closed-Loop Technology on People With Type 1 Diabetes.

Young AJ, Thabit H, Heller SR, Evans ML, Amiel SA, Hovorka R, Barnard KD.

J Diabetes Sci Technol. 2015 Jul;9(4):932-3. doi: 10.1177/1932296815580162. Epub 2015 Apr 7. No abstract available.

4.

Closed loop insulin delivery in diabetes.

Battelino T, Omladič JŠ, Phillip M.

Best Pract Res Clin Endocrinol Metab. 2015 Jun;29(3):315-25. doi: 10.1016/j.beem.2015.03.001. Epub 2015 Mar 10. Review.

PMID:
26051293
5.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.

Bruttomesso D, Farret A, Costa S, Marescotti MC, Vettore M, Avogaro A, Tiengo A, Dalla Man C, Place J, Facchinetti A, Guerra S, Magni L, De Nicolao G, Cobelli C, Renard E, Maran A.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1014-21.

6.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
7.

Future acceptance of an artificial pancreas in adults with type 1 diabetes.

van Bon AC, Brouwer TB, von Basum G, Hoekstra JB, DeVries JH.

Diabetes Technol Ther. 2011 Jul;13(7):731-6. doi: 10.1089/dia.2011.0013. Epub 2011 Apr 19.

PMID:
21504332
8.

Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.

Polsky S, Giordano D, Voelmle MK, Garcetti R, Garg SK.

Postgrad Med. 2016 May;128(4):418-26. doi: 10.1080/00325481.2016.1159910. Epub 2016 Mar 23. Review.

PMID:
26924774
10.

Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia.

Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, Dalla Man C, Place J, Demartini S, Del Favero S, Toffanin C, Hughes-Karvetski C, Dassau E, Zisser H, Doyle FJ 3rd, De Nicolao G, Avogaro A, Cobelli C, Renard E, Kovatchev B; International Artificial Pancreas Study Group.

Diabetes. 2012 Sep;61(9):2230-7. Epub 2012 Jun 11.

11.

Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.

Barnard KD, Wysocki T, Thabit H, Evans ML, Amiel S, Heller S, Young A, Hovorka R; Angela Consortium.

Diabet Med. 2015 May;32(5):601-8. doi: 10.1111/dme.12706. Epub 2015 Feb 20.

PMID:
25615888
12.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.

Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1031-8.

13.

Who needs an artificial pancreas? (?).

Winikoff J, Drexler A.

J Diabetes. 2013 Sep;5(3):254-7. doi: 10.1111/1753-0407.12052. Epub 2013 May 29. Review.

PMID:
23601378
14.

Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.

Del Favero S, Place J, Kropff J, Messori M, Keith-Hynes P, Visentin R, Monaro M, Galasso S, Boscari F, Toffanin C, Di Palma F, Lanzola G, Scarpellini S, Farret A, Kovatchev B, Avogaro A, Bruttomesso D, Magni L, DeVries JH, Cobelli C, Renard E; AP@home Consortium.

Diabetes Obes Metab. 2015 May;17(5):468-76. doi: 10.1111/dom.12440. Epub 2015 Feb 16.

PMID:
25600304
15.

Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.

Wilinska ME, Budiman ES, Taub MB, Elleri D, Allen JM, Acerini CL, Dunger DB, Hovorka R.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1109-20.

16.

Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.

Golden SH, Sapir T.

J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. Review.

PMID:
22984955
17.

Emerging diabetes therapies and technologies.

Moser EG, Morris AA, Garg SK.

Diabetes Res Clin Pract. 2012 Jul;97(1):16-26. doi: 10.1016/j.diabres.2012.01.027. Epub 2012 Feb 29. Review.

PMID:
22381908
18.

Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.

Grosman B, Dassau E, Zisser HC, Jovanovic L, Doyle FJ 3rd.

J Diabetes Sci Technol. 2010 Jul 1;4(4):961-75.

19.

Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.

Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S, Clarke W, Bruttomesso D, Maran A, Costa S, Avogaro A, Dalla Man C, Facchinetti A, Magni L, De Nicolao G, Place J, Farret A.

J Diabetes Sci Technol. 2010 Nov 1;4(6):1374-81.

20.

Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project.

Nimri R, Atlas E, Ajzensztejn M, Miller S, Oron T, Phillip M.

Diabetes Technol Ther. 2012 Aug;14(8):728-35. doi: 10.1089/dia.2012.0004.

PMID:
22853723

Supplemental Content

Support Center